ANNA CLARK: Open Payments
NPI 1932619616 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$850 in 40 payments from 14 companies in 2025. Trend: 2023 $828 · 2024 $426 · 2025 $850
Food & beverage: $850
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 9 | $222 |
| Evofem Biosciences, Inc. | 5 | $92 |
| Sumitomo Pharma America, Inc. | 5 | $83 |
| ABBVIE INC. | 4 | $76 |
| Astellas Pharma US Inc | 3 | $55 |
| Organon LLC | 2 | $48 |
| Sage Therapeutics, LLC | 2 | $46 |
| Supernus Pharmaceuticals, Inc. | 2 | $46 |
| Ethicon US, LLC | 1 | $44 |
| Exeltis, USA Inc. | 2 | $43 |
Products named: Phexxi, MYFEMBREE, UBRELVY, Veozah, NEXPLANON, ZURZUVAE, Qelbree, VISTASEAL.
Industry payments across MO — which companies pay providers there.
